Authors: Andrew Ciupek, PhD, Associate Director, Clinical Research, GO2 for Lung Cancer; Anita K. McGlothlin, Senior Director, Economics & Health Policy, GO2 for Lung Cancer; Angela Criswell, MA, CPS, Director, Quality Screening and Program Initiatives, GO2 for Lung Cancer [...]
Authors: Anita K. McGlothlin, Senior Director, Economics & Health Policy, GO2 for Lung Cancer and Angela Criswell, MA, CPS, Director, Quality Screening and Program Initiatives, GO2 for Lung Cancer Lung cancer screening with a low-dose computed tomography (also known [...]
We recently requested that payers (healthcare insurance companies) expeditiously update their lung cancer screening (LCS) coverage policies in accordance with the recently updated United States Preventive Services (USPSTF) guidelines. In concert with other key stakeholders, letters were sent to [...]
New Medicare Coverage Should Reflect USPSTF Eligibility Thresholds and Reduce Barriers to Care Washington (March 18, 2021) -- Medicare lung cancer screening coverage should be updated to reflect new U.S. Preventive Services Task Force (USPSTF) eligibility thresholds and remove [...]
Today, the United States Preventive Services Task Force (USPSTF) published its final recommendation for low dose CT lung cancer screening, which expands screening recommendations by lowering the age minimum to 50 years and lowering the smoking history to 20-pack [...]
“What About Your Lungs?” Campaign Urges Individuals At-Risk for Lung Cancer to Talk to Their Doctor About Life-Saving Screening Washington, DC [Wednesday, October 31, 2018]—Responding to the need to increase national awareness about lung cancer screening and encourage those [...]
This week, the LCA team attended the 19th Annual World Conference on Lung Cancer (September 23-26, 2018) in Toronto, Canada. Jennifer C. King, PhD, Director of Science and Research, gives us the scoop on some of the research and [...]
